絞り込み

16525

広告

Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study.

著者 Paciaroni M , Agnelli G , Falocci N , Tsivgoulis G , Vadikolias K , Liantinioti C , Chondrogianni M , Bovi P , Carletti M , Cappellari M , Zedde M , Ntaios G , Karagkiozi E , Athanasakis G , Makaritsis K , Silvestrelli G , Lanari A , Ciccone A , Putaala J
J Am Heart Assoc.2017 Nov 29 ; 6(12):.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (115view , 0users)

Full Text Sources

Miscellaneous

The optimal timing to administer non-vitamin K oral anticoagulants (NOACs) in patients with acute ischemic stroke and atrial fibrillation is unclear. This prospective observational multicenter study evaluated the rates of early recurrence and major bleeding (within 90 days) and their timing in patients with acute ischemic stroke and atrial fibrillation who received NOACs for secondary prevention.
PMID: 29220330 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード